Ventas, Inc. (VTR) Stock Analysis
By Nova Skye | AltStation.io | Updated October 29, 2026
Company Overview
Ventas is a real estate investment trust based in Chicago, Illinois, that buys and operates healthcare properties across North America and the United Kingdom. Incorporated in 1983, the company holds an S&P 500 portfolio of approximately 1,450 properties. Its core revenue driver is senior housing, which accounts for more than 900 communities and represents over 62% of its total property count. The remainder of its business comes from leasing outpatient medical buildings, life science research centers, and specialized healthcare facilities to medical operators and aging residents.
Ventas sits as a dominant market leader in healthcare real estate, sharing the top tier of the sector with its chief competitor, Welltower. The company’s primary edge is its massive scale and its proprietary Ventas OI platform, which uses data insights to optimize occupancy, pricing, and operating performance across its portfolio. That technological edge gives Ventas an advantage over smaller, fragmented competitors that lack centralized analytics. Its biggest operational risk comes from rising labor costs and staffing shortages at senior care communities, which can compress operating margins if expenses outpace rent growth.
Right now, Ventas is in aggressive growth mode as demand for senior housing outstrips limited new supply. The company produced double-digit same-store cash net operating income growth above 15% in its senior housing operating portfolio, bolstered by 300 basis points of occupancy gains. Management backed this momentum by completing over $2 billion in senior housing investments in 2024 and another $2.5 billion in 2025. Ventas is not playing defense; it is actively deploying capital to capture high-margin cash flow from an accelerating aging demographic.
52-Week Price Performance Analysis
Recent News and Developments
Q3 normalized FFO rose 10% year over year to $0.99 per share, while attributable net income fell 7% to $0.13 per share. Ventas raised its 2026 normalized FFO range to $3.87-$3.90 per share and its net-income range to $0.64-$0.67. Source: Ventas Investor Relations
Senior Housing Operating Portfolio same-store cash NOI increased 16% year over year, with U.S. NOI up 17% and average U.S. occupancy exceeding 90%. Ventas closed $1.2 billion of senior housing investments during Q3 and $5.2 billion year to date. Source: Ventas Investor Relations
Cantor Fitzgerald reiterated Buy on October 29 but cut its Ventas target from $102 to $95. Wells Fargo maintained Buy while lowering its target from $104 to $96, while Evercore ISI kept Buy with a $100 target and Scotiabank maintained Hold at $95. Source: Stock Analysis
Market Sentiment and Analyst Recommendations
Earnings and Financial Data
Frequently Asked Questions
Related Stock Reports
